Prescription drug · ANDA
Clocortolone Pivalate NDC 51672-4166
Clocortolone pivalate .001 g/g · Cream · Topical · Sun Pharmaceutical Industries, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51672-4166-6 | 51672416606 | 1 TUBE in 1 CARTON (51672-4166-6) / 45 g in 1 TUBEMarketed from Apr 21, 2020 | |
| 51672-4166-8 | 51672416608 | 1 TUBE in 1 CARTON (51672-4166-8) / 90 g in 1 TUBEMarketed from Apr 21, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Clocortolone Pivalate
- Generic name (nonproprietary)
- clocortolone pivalate
- Active ingredients
- Clocortolone pivalate — .001 g/g
- Dosage form
- Cream
- Route
- Topical
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 206370
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 51672-4166_56996baf-3d54-9d1e-e063-6394a90ab576SPL ID 56996baf-3d54-9d1e-e063-6394a90ab576SPL set ID 88d9a7cf-31b5-4b85-9827-0ecce328e6a0RxCUI 197520UNII QBL8IZH14X
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451672416606followed by a unit qualifier and the quantityPackage 51672-4166-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Excerpt only. Read the full label for complete information.